Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer

Abstract

Leuprolide acetate 45 mg 6-month depot demonstrated rapid and sustained testosterone suppression through 12 months and was well tolerated. This 6-month leuprolide acetate depot will decrease the number of annual injections in the treatment of prostate cancer.